HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
Kathryn Lurain(The Ohio State University), Robert Yarchoan(National Cancer Institute), Joseph M. Ziegelbauer(National Institutes of Health), Laurie T. Krug(National Cancer Institute), Denise Whitby(Frederick National Laboratory for Cancer Research), Ramya Ramaswami(National Cancer Institute), Hao‐Wei Wang(Fu Jen Catholic University)
Cited by 37
Related Papers
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
|The Lancet Oncology|2005|378